SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-022825
Filing Date
2021-02-16
Accepted
2021-02-16 07:27:05
Documents
14
Period of Report
2021-02-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm216667d2_8k.htm   iXBRL 8-K 28525
2 EXHIBIT 5.1 tm216667d2_ex5-1.htm EX-5.1 13736
3 GRAPHIC image_001.jpg GRAPHIC 1621
  Complete submission text file 0001104659-21-022825.txt   221968

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tlgt-20210216.xsd EX-101.SCH 3184
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlgt-20210216_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlgt-20210216_pre.xml EX-101.PRE 22709
7 EXTRACTED XBRL INSTANCE DOCUMENT tm216667d2_8k_htm.xml XML 3479
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 856.697.1441
Teligent, Inc. (Filer) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-08568 | Film No.: 21632420
SIC: 2834 Pharmaceutical Preparations